We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Needle-free, live-attenuated influenza vaccines with broad safety in opposition to human and avian virus subtypes
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Needle-free, live-attenuated influenza vaccines with broad safety in opposition to human and avian virus subtypes
Needle-free, live-attenuated influenza vaccines with broad safety in opposition to human and avian virus subtypes
Health

Needle-free, live-attenuated influenza vaccines with broad safety in opposition to human and avian virus subtypes

Last updated: May 10, 2025 8:46 am
Editorial Board Published May 10, 2025
Share
SHARE

HKUMed has achieved a big breakthrough in growing needle-free, live-attenuated influenza vaccines with broad safety in opposition to human and avian virus subtypes. The novel improvements resulted in a number of patents and spectacular accolades on the fiftieth Worldwide Exhibition of Innovations Geneva 2025, together with the Saudi Innovation Excellence Prize and two Gold Medals, certainly one of which got here with Congratulations of the Jury. (From proper: Professor Leo Poon Lit-man and Dr Alex Chin Wing-hong). Credit score: The College of Hong Kong

A analysis crew led by the College of Public Well being within the LKS School of Drugs, the College of Hong Kong (HKUMed), in collaboration with the Heart for Immunology & An infection (C2i), has achieved a big breakthrough in growing broadly protecting, live-attenuated influenza vaccines (LAIV).

These revolutionary LAIV platforms supply potential to develop common influenza vaccines that induce a extra sturdy immune response in opposition to varied virus subtypes, together with each human and avian strains.

These achievements have resulted in a number of patents and accolades on the fiftieth Worldwide Exhibition of Innovations Geneva 2025, together with the Saudi Innovation Excellence Prize and two Gold Medals, certainly one of which got here with Congratulations of the Jury.

Influenza stays a significant respiratory illness, which locations a heavy burden on well being care techniques worldwide. Vaccination is probably the most environment friendly method to stop and management influenza. Present seasonal influenza vaccines, nevertheless, defend primarily in opposition to three chosen strains and require annual updates. Their efficacy can considerably decline if the circulating viruses don’t match the strains chosen every year for every hemisphere.

These vaccines additionally fail to protect in opposition to human infections attributable to animal influenza viruses, reminiscent of avian strains, which pose a possible world pandemic risk. The World Well being Group (WHO) has underscored the pressing want for a brand new era of common influenza vaccines.

The analysis crew developed two revolutionary approaches to create next-generation LAIVs. The primary technique concerned inserting a human α-1,3-galactosyltransferase gene into the genome of a human influenza virus. This modification prompts contaminated host cells to specific the α-Gal epitopes on their floor. Since people naturally produce anti-α-Gal antibodies, this could permit preexisting antibodies to acknowledge cells contaminated by the vaccine, thereby enhancing vaccine-induced immune responses, together with antibody-mediated cytotoxicity, opsonization and phagocytosis.

The analysis information confirmed that the vaccine is attenuated and isn’t pathogenic in mouse fashions. In experiments, vaccinated mice confirmed robust innate and adaptive immune responses, together with antibody and T-cell responses. These immune responses conferred broad safety in opposition to varied influenza A virus subtypes, together with human H1N1 and H3N2, and avian H5N1 strains.

The second method to growing next-generation LAIVs concerned introducing a whole lot of silent mutations to a human influenza virus, shifting its codon utilization from that of a human influenza virus to that of an avian influenza virus-like sample. This shift resulted within the attenuation of the virus in mammalian cells, making it protected to be used as an LAIV. Moreover, the mutant virus replicated completely in rooster eggs, which is essential for present efficient vaccine manufacturing processes.

With this method, the viral protein expression of the LAIV remained similar to the unique wildtype virus, offering a strong immune response in opposition to the viruses. The analysis crew efficiently generated a number of attenuated viruses with totally different human influenza virus backbones, together with H1N1 and H3N2.

The outcomes of in vitro and in vivo experiments confirmed that these viruses had been attenuated in mammalian hosts. They’ll thus be used as LAIVs to guard vaccinated mice from totally different subtypes of influenza A virus an infection, together with the human H1N1 and H3N2 viruses, in addition to the avian H5N1 and H7N9 influenza viruses.

The event of those two award-winning LAIVs represents a big development within the quest for broadly protecting and environment friendly influenza vaccines. This new era of LAIVs can each defend people from seasonal influenza viruses and handle the risk posed by rising viruses, like avian influenza viruses.

“The advantages of LAIVs lie in their intranasal administration, which has been shown to induce mucosal immune responses along the respiratory tract, providing additional protection against infection,” mentioned Professor Leo Poon Lit-man, Chair Professor of Public Well being Virology and Head of the Division of Public Well being Laboratory Sciences, College of Public Well being, HKUMed. “This needle-free delivery method alleviates the fear of vaccination, particularly in young children, so it will help mitigate vaccine hesitancy.”

These scientific breakthroughs symbolize a promising step in the direction of a future during which influenza vaccines can supply complete safety in opposition to a wide selection of viral threats. Transferring ahead, the analysis crew will leverage the worldwide platform of the Hong Kong Jockey Membership International Well being Institute (HKJCGHI) for additional growth, guaranteeing continued progress and making a worldwide impression on this important space.

“Both HKUMed and the International Vaccine Institute (IVI), one of the collaborators of the HKJCGHI, have initiated discussions and contributed intellectual input towards the vaccine development,” mentioned Professor Leo Poon Lit-man, who can also be the Co-Director of HKJCGHI. “It is anticipated that in the near future, further studies, including research work adhering to Good Laboratory Practice (GLP) standards, will be conducted through the resources of the Institute.”

Offered by
The College of Hong Kong

Quotation:
Needle-free, live-attenuated influenza vaccines with broad safety in opposition to human and avian virus subtypes (2025, Might 9)
retrieved 10 Might 2025
from https://medicalxpress.com/information/2025-05-needle-free-attenuated-influenza-vaccines.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

You Might Also Like

Working girls are too usually left to take care of endometriosis alone. However huge modifications might be coming

Early prediction of preterm start in cell-free RNA may reshape prevention methods

Extra will be executed to stop widespread sort of stroke, say consultants

Novel immune cell inhabitants might supply various goal for tuberculosis vaccines

Hay fever: Why signs are so unhealthy this 12 months, and what to do in case your common treatments aren’t working

TAGGED:avianbroadHumanInfluenzaliveattenuatedNeedlefreeProtectionsubtypesvaccinesvirus
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
New York State DOT marks ‘Star Wars Day’ with street indicators in Yoda-speak
Politics

New York State DOT marks ‘Star Wars Day’ with street indicators in Yoda-speak

Editorial Board May 5, 2025
Beneath her eye: The blessings of Ann Dowd as Aunt Lydia in ‘The Handmaid’s Story’
Adrienne Adams rises in NYC mayoral race ballot, but can’t unlock matching funds
Special Master Expresses Skepticism of Declassification Claims by Trump’s Lawyers
New chook flu mutation found in US as cat infections trigger alarm

You Might Also Like

Swept-source anterior section optical coherence tomography can assist distinguish early childhood glaucoma
Health

Swept-source anterior section optical coherence tomography can assist distinguish early childhood glaucoma

May 24, 2025
Hundreds of thousands of HealthCare.gov contributors face protection loss on account of burdensome reenrollment insurance policies
Health

Hundreds of thousands of HealthCare.gov contributors face protection loss on account of burdensome reenrollment insurance policies

May 24, 2025
US extra deaths proceed to rise even after the COVID-19 pandemic, research finds
Health

US extra deaths proceed to rise even after the COVID-19 pandemic, research finds

May 24, 2025
Organ-specific irritation masquerades as relapse in CAR T-cell remission
Health

Organ-specific irritation masquerades as relapse in CAR T-cell remission

May 24, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?